Are there any health issues with low hsCRP?

While low hsCRP levels (below 1 mg/L) are generally considered healthy and indicate minimal inflammation, extremely low levels may occasionally mask underlying conditions or reflect nutritional deficiencies. Most people with low hsCRP have reduced cardiovascular risk and better overall health outcomes.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding hsCRP and Its Role in Your Body

High-sensitivity C-reactive protein (hsCRP) is a blood biomarker that measures inflammation levels throughout your body. Produced by the liver in response to inflammatory signals, hsCRP has become one of the most important markers for assessing cardiovascular disease risk and overall inflammatory status. While much attention focuses on elevated hsCRP levels and their associated health risks, questions about low hsCRP levels are equally important for understanding your complete health picture.

Unlike many biomarkers where both high and low levels can indicate problems, hsCRP is somewhat unique. Low levels are typically celebrated as a sign of good health, minimal inflammation, and reduced disease risk. However, understanding what constitutes truly low hsCRP and whether there are any potential downsides helps you interpret your test results more effectively.

What Are Normal and Low hsCRP Levels?

Understanding hsCRP levels requires knowing the standard reference ranges used in clinical practice. These ranges help healthcare providers assess cardiovascular risk and overall inflammatory status.

hsCRP Level Categories and Clinical Significance

hsCRP Level (mg/L)Risk CategoryClinical InterpretationRecommended Actions
<1.0<1.0 mg/LLow RiskMinimal inflammation, optimal cardiovascular healthMaintain healthy lifestyle
1.0-3.01.0-3.0 mg/LModerate RiskAverage inflammation, moderate cardiovascular riskConsider lifestyle modifications
>3.0>3.0 mg/LHigh RiskElevated inflammation, increased cardiovascular riskAggressive risk reduction needed
>10.0>10.0 mg/LAcute PhaseLikely acute infection or inflammationRetest after acute event resolves

hsCRP levels should be interpreted alongside other cardiovascular risk factors and clinical context.

Most laboratories consider hsCRP levels below 1.0 mg/L as low risk, with levels below 0.5 mg/L being particularly favorable. Some individuals maintain hsCRP levels below 0.2 mg/L, which represents minimal systemic inflammation. These very low levels are often seen in people who maintain healthy lifestyles, including regular exercise, nutritious diets, stress management, and adequate sleep.

Factors That Influence hsCRP Levels

Several factors can affect your hsCRP levels, both positively and negatively:

  • Physical activity: Regular exercise typically lowers hsCRP
  • Diet quality: Anti-inflammatory foods reduce hsCRP levels
  • Body weight: Higher BMI often correlates with elevated hsCRP
  • Smoking status: Tobacco use increases inflammation markers
  • Sleep quality: Poor sleep can elevate inflammatory markers
  • Stress levels: Chronic stress contributes to higher hsCRP
  • Age: hsCRP tends to increase slightly with aging
  • Medications: Statins, aspirin, and other drugs can lower hsCRP

The Benefits of Low hsCRP Levels

Having low hsCRP levels is generally associated with numerous health benefits and reduced disease risks. Research consistently shows that individuals with hsCRP levels below 1.0 mg/L have significantly lower rates of cardiovascular events, including heart attacks and strokes. This protective effect extends beyond heart health to encompass overall longevity and quality of life.

Cardiovascular Protection

Low hsCRP levels indicate minimal inflammation in blood vessels, which translates to reduced atherosclerosis risk. Studies have shown that people with hsCRP levels below 1.0 mg/L have up to 50% lower risk of cardiovascular events compared to those with levels above 3.0 mg/L. This protection appears independent of other risk factors like cholesterol levels, making hsCRP a valuable additional marker for heart health assessment.

Metabolic Health Benefits

Low inflammation levels, as reflected by low hsCRP, are associated with better metabolic health outcomes. People with low hsCRP typically have improved insulin sensitivity, better blood sugar control, and lower risk of developing type 2 diabetes. They also tend to maintain healthier body weights and have more favorable lipid profiles, creating a positive cycle of metabolic wellness.

Potential Concerns with Very Low hsCRP

While low hsCRP is generally positive, extremely low levels in certain contexts may warrant consideration. It's important to understand that hsCRP is just one marker among many, and interpreting it requires considering your complete health picture. Regular monitoring of your inflammatory markers alongside other key biomarkers provides the most comprehensive view of your health status.

Immune System Considerations

CRP plays a role in the immune system's response to infections and tissue damage. While having low baseline hsCRP is healthy, your body should be capable of mounting an appropriate inflammatory response when needed. Some researchers have questioned whether extremely low hsCRP might indicate an underactive immune response, though this remains largely theoretical. Most people with low hsCRP maintain normal immune function and can produce appropriate inflammatory responses when faced with infections or injuries.

Masking Other Conditions

In rare cases, very low hsCRP might mask certain inflammatory conditions that would typically elevate this marker. Some autoimmune conditions, chronic infections, or malignancies might not produce the expected hsCRP elevation in certain individuals. This is why comprehensive health assessment should never rely on a single biomarker but should include multiple inflammatory markers, clinical symptoms, and other diagnostic tests when indicated.

Medical Conditions Associated with Low hsCRP

While low hsCRP is typically a sign of good health, certain medical conditions and situations can result in lower than expected hsCRP levels:

  • Liver dysfunction: Since the liver produces CRP, severe liver disease might impair CRP production
  • Certain medications: Some immunosuppressive drugs may lower CRP production
  • Genetic variations: Rare genetic polymorphisms can affect CRP synthesis
  • Malnutrition: Severe protein deficiency might impact CRP production
  • Some autoimmune conditions: Certain conditions may paradoxically present with low inflammation markers

It's crucial to note that these situations are relatively uncommon, and most people with low hsCRP simply have minimal inflammation due to healthy lifestyle factors. If you have concerns about your hsCRP levels in the context of other symptoms or health conditions, discussing them with your healthcare provider ensures appropriate evaluation and interpretation.

Optimizing Your hsCRP Levels

If your hsCRP levels are already low, maintaining them through healthy lifestyle practices supports long-term health. If your levels are higher than optimal, several evidence-based strategies can help reduce inflammation:

Dietary Approaches

An anti-inflammatory diet rich in whole foods, omega-3 fatty acids, and antioxidants effectively lowers hsCRP levels. Focus on:

  • Fatty fish like salmon, mackerel, and sardines
  • Colorful fruits and vegetables high in polyphenols
  • Nuts and seeds, particularly walnuts and flaxseeds
  • Whole grains instead of refined carbohydrates
  • Olive oil as a primary fat source
  • Green tea and other antioxidant-rich beverages
  • Limiting processed foods, added sugars, and trans fats

Exercise and Physical Activity

Regular physical activity is one of the most effective ways to reduce chronic inflammation. Both aerobic exercise and resistance training lower hsCRP levels, with the greatest benefits seen in those who combine both types of activity. Aim for at least 150 minutes of moderate-intensity exercise weekly, along with two sessions of strength training.

When to Test Your hsCRP Levels

Testing hsCRP provides valuable insights into your inflammatory status and cardiovascular risk. Consider testing if you have risk factors for heart disease, family history of cardiovascular problems, or want to optimize your health through data-driven decisions. Regular monitoring helps track your progress and ensures your inflammation levels remain in the healthy range.

Timing of hsCRP testing matters for accurate results. Avoid testing during acute illness, injury, or infection, as these temporarily elevate CRP levels. Wait at least two weeks after any acute inflammatory event before testing. For monitoring purposes, testing every 3-6 months allows you to track trends and assess the effectiveness of lifestyle interventions.

Interpreting Your Results in Context

Understanding your hsCRP results requires considering them alongside other health markers and your individual circumstances. Low hsCRP combined with optimal levels of other cardiovascular markers like lipids, blood pressure, and glucose indicates excellent heart health. However, even with low hsCRP, addressing other risk factors remains important for comprehensive disease prevention.

Your healthcare provider can help interpret your results in the context of your complete health picture, including family history, lifestyle factors, and other biomarkers. This comprehensive approach ensures you receive personalized recommendations for maintaining or achieving optimal health.

The Bottom Line on Low hsCRP

Low hsCRP levels are overwhelmingly positive for your health, indicating minimal inflammation and reduced risk for numerous chronic diseases. While theoretical concerns about extremely low levels exist, they rarely translate into clinical problems for most people. The vast majority of individuals with low hsCRP enjoy better cardiovascular health, improved metabolic function, and enhanced overall wellbeing.

Rather than worrying about low hsCRP levels, focus on maintaining them through healthy lifestyle choices. Regular exercise, nutritious eating, stress management, and adequate sleep create an anti-inflammatory environment in your body. Combined with periodic monitoring of your inflammatory markers and other key biomarkers, you can optimize your health for the long term while enjoying the protective benefits of low inflammation.

References

  1. Ridker, P. M. (2016). A Test in Context: High-Sensitivity C-Reactive Protein. Journal of the American College of Cardiology, 67(6), 712-723.[Link][DOI]
  2. Emerging Risk Factors Collaboration. (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet, 375(9709), 132-140.[PubMed][DOI]
  3. Pearson, T. A., et al. (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107(3), 499-511.[PubMed][DOI]
  4. Kushner, I., Rzewnicki, D., & Samols, D. (2006). What does minor elevation of C-reactive protein signify? The American Journal of Medicine, 119(2), 166.e17-166.e28.[PubMed][DOI]
  5. Kasapis, C., & Thompson, P. D. (2005). The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. Journal of the American College of Cardiology, 45(10), 1563-1569.[PubMed][DOI]
  6. Calder, P. C., et al. (2011). Dietary factors and low-grade inflammation in relation to overweight and obesity. British Journal of Nutrition, 106(S3), S5-S78.[PubMed][DOI]

Frequently Asked Questions

How can I test my hsCRP at home?

You can test your hsCRP at home with SiPhox Health's Core Health Program, which includes hsCRP testing along with other essential cardiovascular and metabolic markers. This CLIA-certified program provides lab-quality results from the comfort of your home, allowing you to monitor your inflammation levels regularly.

Can hsCRP be too low?

While extremely low hsCRP levels (below 0.2 mg/L) are uncommon, they're generally not concerning in healthy individuals. These very low levels typically indicate excellent anti-inflammatory status rather than a problem. However, if accompanied by other symptoms or in the context of certain medical conditions, discussion with your healthcare provider ensures appropriate evaluation.

What's the difference between CRP and hsCRP?

Standard CRP tests measure higher levels of inflammation typically seen in acute infections or injuries. High-sensitivity CRP (hsCRP) can detect much lower levels of inflammation, making it useful for assessing cardiovascular risk and chronic low-grade inflammation. The 'high-sensitivity' refers to the test's ability to measure small amounts of CRP, not higher levels.

How quickly can hsCRP levels change?

hsCRP levels can change relatively quickly in response to acute events like infections or injuries, rising within hours and potentially staying elevated for days. However, changes in baseline hsCRP due to lifestyle modifications typically occur over weeks to months. Consistent healthy habits produce the most stable and beneficial long-term reductions in hsCRP.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details